Hypoxia regulates the natriuretic peptide system

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 3, Issue 3, 2011, Pages 191-201

  Arjamaa, Olli ^a   Nikinmaa, Mikko ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; OXYGEN;

APNEA; ARTICLE; BLOOD OXYGEN TENSION; DIURESIS; DNA RESPONSIVE ELEMENT; HEART VENTRICLE WALL; HEMOCONCENTRATION; HORMONE SYNTHESIS; HUMAN; HYPERVOLEMIA; HYPOXIA; NATRIURESIS; NONHUMAN; OXYGEN TRANSPORT; PLASMA VOLUME; PROTEIN BLOOD LEVEL; WALL STRESS;

EID: 80053023113     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (121)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981; 28: 89-94.
2. Flynn TG, de Bold ML, de Bold MJ. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983: 117: 859-865.
3. Atlas SA, Kleinert HD, Camargo MJ, Januszewicz A, Sealey JE, Laragh JH, Schilling JW, Lewicki JA, Johnson LK, Maack T. Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptides. Nature 1984; 309: 717-719.
4. Currie MG, Geller DM, Cole BR, Siegel NR, Adams SP, Eubanks SR, Galluppi GR, Needleman P. Purification and sequence analysis of bioactive atrial peptides (Atriopeptins). Science 1984; 223: 67-69.
5. Kangawa K, Tawaragi Y, Oikawa S, Mizuno A, Sakuragawa Y, Nakazato H, Fukuda A, Minamino N, Matsuo H. Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature 1984; 312: 152-154.
6. Misono KS, Fukumi H, Grammer RT, Inagami T. Rat Atrial Natriuretic Factor: Complete amino acid sequence and disulfide linkage essential for biological activity. Biochem Bio phys Res Commun 1984; 119: 524-529.
7. Seidah NG, Lazure C, Chrétien M, Thibault G, Garcia R, Cantin M, Genest J, Nutt RF, Brady SF, Lyle TA, Paleveda WJ, Colton CD, Ciccarone TM, Veber D. Amino acid sequence of homologous rat atrial peptides: Natriuretic activity of native and synthetic forms. Proc Natl Acad Sci USA 1984; 81: 2640-2644.
8. Seidman CE, Duby AD, Choi E, Graham RM, Haber E, Homcy C, Smith JA, Seidman JG. The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. Science 1984; 224: 324-326.
9. Gutkowska J, Thibault G, Januszewicz P, Cantin M, Genest J. Direct radioimmunoassay of atrial natriuretic factor. Biochem Biophys Res Commun 1984; 122: 593-601.
10. Nakao K, Sugawara A, Morii N, Sakamoto M, Suda M, Soneda J, Ban T, Kihara M, Yamori Y, Shimokura M, Kiso Y, Imura H. Radioimmunoassay for alpha-human and rat atrial natriuretic polypeptide. Biochem Biophys Res Commun 1984; 124: 815-821.
11. Richards AM, Ikram H, Yandle TG, Nicholls MG, Webster MW, Espiner EA. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1985; 325: 545-549.
12. Kisch B. A significant electron microscopic difference between the atria and the ventricles of the mammalian heart. Exp Med Surg 1963; 21: 193-221.
13. Jamieson JD, Palade GE. Specific granules in atrial muscle cells. J Cell Biol 1964; 23: 151-172.
14. de Wardener WE, Clarkson EM. Concept of natriuretic hormone. Physiol Rev 1985; 65: 658-759.
15. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991; 88: 6259-6263.
16. Arjamaa O, Nikinmaa M. Review. Natriuretic peptides in hormonal regulation of hypoxia responses. Am J Physiol 2009; 296: R257-R264.
17. Takei Y. Does the natriuretic peptide system exist throughout the animal and plant kingdom? J Comp Biochem Physiol B: Biochem Mol Biol 2001; 129: 559-571.
18. Toop T, Donald JA. Comparative aspects of natriuretic peptide physiology in nonmammalian vertebrates: a review. J Comp Physiol B: Biochem Systemic Environ Physiol 2004; 174: 189-204.
19. Gardner DG, Songcang C, Glenn DJ, Grigsby CL. Molecular biology of the natriuretic peptide system. Implications for physiology and hypertension. Hypertension 2007; 49: 419-426.
20. Richards AM. Natriuretic peptides: Update on peptide release, bioactivity, and clinical use. Hypertension 2007; 12: 331-343.
21. Clerico A, Giannoni A, Vittorini S, Passino C. Thirty years of the heart as an endocrine organ: Physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol 2011; Epub ahead of print.
22. Johnson KR, Olson KR. Comparative physiology of the piscine natriuretic peptide system. Gen Comp Endocrinol 2008; 157: 21-26.
23. Schelbert HR. Anatomy and physiology of coronary blood flow. J Nucl Cardiol 2010; 17: 545-554.
24. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008; 88: 1009-1088.
25. Dempsey JA, Wagner PD. Exercise-induced arterial hypoxemia. J Appl Physiol 1999; 87: 1997-2006.
26. Kaijser L, Grubbstrom J, Berglund B. Coronary circulation in acute hypoxia. Clin Physiol 1990; 10: 259-263.
27. Takahashi E, Doi K. Review. Impact of diffusional oxygen transport on oxidative metabolism in the heart. Jap J Physiol 1998; 48: 243-252.
28. Zuurbier CJ, van Iterson M, Ince C. Review. Functional heterogeneity of oxygen supplyconsumption ratio in the heart. Cardiovasc Res 1999; 44: 488-497.
29. Winter RJ, Meleagros L, Pervez S, Jamal H, Krausz T, Polak JM, Bloom SR. Atrial natriuretic peptide levels in plasma and cardiac tissues after chronic hypoxia in rats. Clin Sci 1989; 76: 95-101.
30. Stockmann PT, Will DH, Sides SD, Brunnert SR, Wilner GD, Leahy KM, Wiegand RD, Needleman P. Reversible induction of right ventricular atriopeptin synthesis in hypertrophy due to hypoxia. Circ Res 1988; 63: 207-213.
31. McKenzie JC, Kelley KB, Merisko-Liversidge EM, Kennedy J, Klein RM. Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophied process. J Mol Cell Cardiol 1994; 26: 1753-1767.
32. Sharma S, Taegtmeyer H, Adrogue J, Razeghi P, Sen S, Ngumbela K, Essop MF. Dynamic changes of gene expression in hypoxiainduced right ventricular hypertrophy. Am J Physiol 2004; 286: H1185-H1192.
33. Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, Prabhakar NR. Oxygen sensing in the body. Progr Biophys Mol Biol 2006; 96: 249-286.
34. Chun YS, Hyun JY, Kwak YG, Kim IS, Kim CH, Choi E, Kim MS, Park JW. Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxiainducible factor-1. Biochem J 2003; 370: 149-157.
35. Luo Y, Jiang C, Belangor AJ, Akita GY, Wadsworth SC, Gregory RJ, Vincent KA. A constitutively active hypoxia-inducible factor-1α/ VP16 hybrid factor activates expression of the human B-type natriuretic peptide gene. Mol Pharmacol 2006; 69: 1953-1962.
36. Wilhide ME, Jones WK. Potential therapeutic gene for the treatment of ischemic disease: Ad2/hypoxia-inducible factor-1α (HIF-1)/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element. Mol Pharmacol 2006; 69: 1773-1778.
37. Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, Eckardt KU, Warnecke C. Hypoxia, via stimulation of the hypoxia-inducible factor HIF-1α, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J 2008; 409: 233-242.
38. Casals G, Ros J, Sionis A, Davidson MM, Morales-Ruiz M, Jiménez W. Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes. Am J Physiol 2009; 97: H550-H555.
39. Edlund A, Wennmalm A. Oxygen consumption in rabbit Langendorff hearts perfused with saline medium. Acta Physiol Scand 1981; 113: 117-122.
40. Hülsman WC, de Wit LEA. Acidosis, cardiac stunning and its prevention. Cell Biol Int Reports 1990; 14: 311-315.
41. Murashita T, Kempsford RD, Hearse, DJ. Oxygen supply and oxygen demand in the isolated working rabbit heart perfused with asanguinous crystalloid solution. Cardiovasc Res 1991; 25: 198-206.
42. Beard DA, Schenkman KA, Feigl EO. Myocardial oxygenation in isolated hearts predicted by an anatomically realistic microvascular transport model. Am J Physiol 2003; 283: H1826-H1836.
43. Schenkman KA, Beard DA, Ciesielski WA, Feigl EO. Comparison of buffer and red blood cell perfusion of guinea pig heart oxygenation. Am J Physiol 2003; 285: H1819-H1825.
44. Ejike JC, Arakaki L, Beard DA, Ciesielski WA, Feigl EO, Schenkman KA. Myocardial oxygenation and adenosine release in isolated guinea pig hearts during changes in contractility. Am J Physiol 2005; 288: H2062-H2067.
45. Ashruf JF, Ince C, Bruining HA. Regional ischemia in hypertrophied Langendorff-perfused rat hearts. Am J Physiol 1999; 46: H1532-H1539.
46. Baertschi AJ, Hausmaninger C, Walsh RS, Mentzer RM. Jr, Wyatt DA, Pence RA. Hypoxiainduced release of atrial natriuretic factor (ANF) from the isolated rat and rabbit heart. Biochem Biophys Res Commun 1986; 140: 427-433.
47. Lew RA, Baertschi AJ. Mechanisms of hypoxiainduced atrial natriuretic factor release from rat hearts. Am J Physiol 1989; 257: H147-H156.
48. Chen BN, Rayner TE, Menadue MF, McLennan PL, Oliver JR. Effect of ischemia and role of eicosanoids in release of atrial natriuretic factor from rat heart. Cardiovasc Res 1993; 27: 1576-1579.
49. Zhang Y, Oliver JR, Horowitz, JD. The role of endothelin in mediating ischemia/hypoxiainduced atrial natriuretic peptide release. J Cardiovasc Pharmacol 2004; 43: 227-233.
50. Naruse M, Higashida T, Naruse K, Shibasaki T, Demura H, Ingami T, Shizume K. Coronary hemodynamics and cardiac beating modulate atrial natriuretic factor release from isolated Langendorff-perfused rat hearts. Life Sci 1987; 49: 421-427.
51. Toth M, Vuorinen KH, Vuolteenaho O, Hassinen IE, Uusimaa PA, Leppäluoto J, Ruskoaho H. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 1994; 266: H1572-H1580.
52. Uusimaa PA, Peuhkurinen KJ, Hassinen IE, Vuolteenaho O, Ruskoaho H. 1992a. Ischemia stimulates the release of atrial natriuretic peptide from rat cardiac ventricular myocardium in vitro. Life Sci 1992a; 52: 365-373.
53. Uusimaa PA, Peuhkurinen KJ, Vuolteenaho O, Ruskoaho H, Hassinen IE. Role of myocardial redox and energy states in ischemiastimulated release of atrial natriuretic peptide. J Mol Cell Cardiol 1992b; 24: 191-205.
54. Arad M, Zamir N, Horowitz L, Oxman T, Rabinowit, B. Release of atrial natriuretic peptide in brief ischemia-reperfused in isolated rat hearts. Am J Physiol 1994; 266: H1971-H1978.
55. Focaccio A, Ambrosio G, Enea I, Russo R, Balestrieri P, Chiariello M, Volpe M. Influence of O2 deprivation, reduced flow, and temperature on release of ANP from rabbit hearts. Am J Physiol 1995; 268: H2352-H2357.
56. Ljusegren ME, Andersson RG. Hypoxia induces release of atrial natriuretic peptide in rat atrial tissue: a role for this peptide during low oxygen stress. Naunyn Schmiedebergs Arch Pharmacol 1994; 350: 189-193.
57. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congential heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004; 109; 2872-2877.
58. Klinger JR, Pietras L, Warburton R, Hill NS. Reduced oxygen tension increases atrial natriuretic peptide release from atrial cardiocytes. Exp Biol Med 2001; 226: 847-853.
59. Casserly B, Pietras L, Schuyler J, Wang R, Hill NS, Klinger JR. Cardiac atria are the primary source of ANP release in hypoxia-adapted rats. Life Sci 2010; 87: 382-389.
60. Möllmann H, Nef HM, Kostin S, Dragu A, Maack C, Weber M, Troidi C, Rolf A, Elsässer A, Böhm M, Brantner R, Hamm CW, Holubarsch CJ. Ischemia triggers BNP expression in the human myocardium independent from mechanical stress. Int J Cardiol 2010; 143: 289-297.
61. Baertschi AJ, Adams JM, Sullivan MP. Acute hypoxemia stimulates atrial natriuretic factor secretion in vivo. Am J Physiol 1988; 255; H295-H300.
62. Lawrence DL, Skatrud JB, Shenker Y. Effect of hypoxia on atrial natriuretic factor and aldosterone regulation in humans. Am J Physiol 1990; 258: E243-E438.
63. De Angelis C, Ferri C, Urbani L, Farrac, S. Effect of acute exposure to hypoxia on electrolytes and water metabolism regulatory hormones. Aviat Space Environ Med 1996; 67: 746-750.
64. Due-Andersen R, Pedersen-Bjergaard U, Høi- Hansen N, Olsen NV, Kistorp C, Faber J, Boomsma F, Thorsteinsson B. NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system. J Appl Physiol 2008; 104: 1080-1085.
65. Cheung CY, Brace RA. Fetal hypoxia elevates plasma atrial natriuretic factor concentration. Am J Obstet Gynecol 1988; 159: 1263-1268.
66. Johnson DD, Singh BM, Cheung CY. Effect of three hours of hypoxia on atrial natriuretic factor gene expression in the ovine fetal heart. Am J Obstet Gynecol 1997; 176: 42-48.
67. Ogunyemi DA, Koos BJ, Arora CP, Castro LC, Mason BA. Adenosine modulates hypoxiainduced atrial natriuretic peptide release in fetal sheep. Am J Physiol 1995; 269: H282-H287.
68. Baertschi AJ, Teague WG. Alveolar hypoxia is a powerful stimulus for ANF release in conscious lambs. Am J Physiol 1989; 256: H990-H998.
69. Goetze JP, Gore A, Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004; 18: 1928-1930.
70. Khan AR, Birbach M, Cohen MS, Ittenbach RF, Spray TL, Levy RJ, Gaynor JW. Chronic hypoxemia increases ventricular brain natriuretic peptide precursors in neonatal swine. Ann Thorac Surg 2008; 85: 618-623.
71. Zenteno-Savin T, Castellini MA. Changes in the plasma levels of vasoactive hormones during apnea in seals. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998; 119: 7-12.
72. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from Heart and Soul study. Circulation 2003; 108: 2987-2992.
73. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, Nielsen LB. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105-1107.
74. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Müller KD, Berkovitsch A, Mitrovic, V, Hamm C. N-terminal B-type natriuretic peptide predicts extent coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 2004; 148: 612-620.
75. Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME, Müller-Brand J, Perruchoud AP, Müller C. Use of N-terminal pro-Btype natriuretic peptide to detect myocardial ischemia. Am J Med 2005; 118: 1287.e9-16.
76. Navarro Estrada JL, Rubinstein F, Bahit MC, Rolandi F, Perez de Arenaza D, Gabay JM, Alvarez J, Sarmiento R, Rojas Matas C, Sztejfman C, Tettamanzi A, de Miguel R, Guzman L. PACS Investigators. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes. Am Heart J 2006;151;1093.e1- 1093.e7.
77. Wolber T, Maeder M, Rickli H, Riesen W, Binggeli C, Duru F, Ammann P. N-terminal probrain natriuretic peptide used for the prediction of coronary artery stenosis. Eur J Clin Invest 2007; 37: 18-25.
78. Nadir MA, Witham DM, Szwejkowski, BR, Struthers AD. Meta-analysis of B-type natriuretic peptide's ability to identify stress induced myocardial ischemia. Am J Cardiol 2011; 107: 662-667.
79. Baibars M, Ibrahim A, Fang JC, Sipahi I. Editorial. Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy. Future Cardiol 2010; 6: 743-747.
80. Christenson RH. What is the value of B-type natriuretic peptide testing for diagnosis, prognosis or monitoring of critically ill adult patients in intensive care unit? Clin Chem Lab Med 2008; 46: 1524-1532.
81. Omland T. Advances in congestive heart failure management in the intensive care unit: Btype natriuretic peptides in evaluation of acute heart failure. Crit Care Med 2008; 36: S17-S27.
82. Müller C, Maisel A, Mebazaa, Filippatos GS. The use of B-type natriuretic peptides in the intensive care units. Congest Heart Fail 2008; 14: 43-45.
83. Nikinmaa M. Vertebrate red blood cells. 1990. Berlin: Springer-Verlag.
84. Nikinmaa M. Membrane transport and the control of haemoglobin-oxygen affinity in nucleated erythrocytes. Physiol Rev 1992: 72: 301-321.
85. Isbister JP. Physiology and pathophysiology of blood volume regulation. Transfus Sci 1997; 18: 409-423.
86. Nikinmaa M. Haemoglobin function in verte brates: evolutionary changes in cellular regulation in hypoxia. Respir Physiol 2001; 128: 301-321.
87. Nilsson S. Autonomic nerve function in the vertebrates. 1983. Berlin: Springer-Verlag.
88. Grant WS, Root WS. Fundamental stimulus for erythropoiesis. Physiol Rev 1952;42: 449-498.
89. Westerndorp RG, Roos AN, van der Hoeven HG, Tjiong MY, Simons R, Frölich M, Souverijn JH, Meinders AE. Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia. Am Rev Respir Dis 1993; 148: 304-309.
90. Wijeyaratne CN, Moult PJ. The effect of alpha human natriuretic peptide on plasma volume and vascular permeability in normotensive subjects. J Clin Endocrinol Metab 1993; 76: 343-346.
91. Almeida FA, Suzuki M, Maack T. Atrial natriuretic factor increases hematocrit and decrease plasma volume in nephrectomized rats. Life Sci 1986; 39: 1193-1199.
92. Albert TS, Tucker VL, Renkin, EM. Atrial natriuretic peptide levels and plasma volume contraction in acute alveolar hypoxia. J Appl Physiol 1997; 82: 102-110.
93. 2 modulation of singlevessel hydraulic conductance. Am J Physiol 1988; 254: H317-H323.
94. Huxley VH, Tucker VL, Verburg KM, Freeman RH. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circ Res 1987; 60: 304-307.
95. Huxley VH, Meyer DJ Jr. Atrial natriuretic peptide (ANP)-induced increase in capillary albumin and water flux. Adv Exp Med Biol 1988; 242: 23-31.
96. Richards AM, McDonald D, Fizpatrik MA, Nicholls MG, Espiner EA, Ikram H, Jans S, Grant S, Yandle T. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988; 67: 1134-1139.
97. Rinne A, Vuolteenaho O, Järvinen M, Dorn A, Arjamaa O. Atrial natriuretic polypeptides in the specific atrial granules of the rat heart: Immunohistochemical and radioimmunological quantification. Acta Histochem 1986; 80: 19-28.
98. Wang ZZ, He L, Stensaas LJ, Dinger BG, Fidone SJ. Localization and in vitro actions of atrial natriuretic peptide in the cat carotid body. J Appl Physiol 1991; 70:942-946.
99. Wang WJ, He L, Chen J, Dinger D, Fidone S. Mechansims underlying chemoreceptor inhibition induced by atrial natriuretic peptide in rabbit carotid body. J Physiol 1993; 460: 427-441.
100. He L, Dinger B, Fidone S. Cellular mechanisms involved in carotid body inhibition produced by atrial natriuretic peptide. Am J Physiol 2000; 278; C845-C852.
101. Di Giulio C, Huang W, Waters V, Mkashi A, Bianchi G, Cacchio M, Macri MA, Lahiri S. Atrial natriuretic peptide stimulates cat carotid body chemoreceptors in vivo. Comp Biochem Physiol A Mol Integr Physiol 2003; 134: 27-31.
102. Al-Obaidi M, Whitaker EM, Karim F. The effect of discrete stimulation of carotid body chemoreceptors on atrial natriuretic peptide in anaesthetized dogs. J Physiol 1991; 443: 519-531.
103. Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor: a circulating hormone stimulated by volume loading. Nature 1985; 314: 264-266.
104. Fyrenius A, Wigström L, Ebbers T, Karlsson M, Engvall J, Bolger AF. Three dimensional flow in the human left atrium. Heart 2001; 86: 448-455.
105. Sakata M, Greenwald JE, Needleman P. Paradoxical relationship between atriopeptin plasma levels and diuresis-natriuresis induced by acute volume expansion. Proc Natl Acad Sci USA 1988; 85: 3155-3159.
106. Antunes-Rodrigues J, Ramalho MJ, Reis LC, Menani JV, Turrin MQ, Gutkowska J, McCann SM. Lesions of the hypothalamus and pituitary inhibit volume-expansion-induced release of atrial natriuretic peptide. Proc Natl Acad Sci USA 1991; 88: 2956-2960.
107. Gutkowska J, Antunes-Rodrigues J, McCann SM. Atrial natriuretic peptide in brain and pituitary gland. Physiol Rev 1997; 77: 465-515.
108. Jiao JH, Baertschi AJ. Neural control of the endocrine heart. Proc Natl Acad Sci USA 1993; 90: 7799-7803.
109. Winquist RJ. The relaxant effects of atrial natriuretic factor on vascular smooth muscle. Life Sci 1985; 37: 1081-1087.
110. Winquist RJ. Possible mechanisms underlying the vasorelaxant response to atrial natriuretic factor. Fed Proc 1986; 45: 2371-2375.
111. Winquist RJ. Modulation of vascular tone by atrial natriuretic factor. Blood Vessels 1987; 24: 128-131.
112. Kawai Y, Ohhashi T. Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide. Can J Physiol Pharmacol 1989; 67: 326-330.
113. Shirai M, Ninomiya I, Shindo, T. Selective and tone-dependent vasodilatation of arterial segment in rabbit and feline pulmonary microcirculation in response to ANP. Jpn J Physiol 1993; 43: 485-99.
114. Endlich K, Steinhausen M. Natriuretic peptide receptors mediate different responses in rat renal microvessels. Kidney Int 1997; 52: 202-207.
115. Winquist RJ, Hintze TH. Mechanisms of atrial natriuretic factor-induced vasodilatation. Pharmacol Ther 1990; 48: 417-422.
116. Burnett JC Jr, Rubanyi GM, Edwards BS, Schwab TR, Zimmermann RS, Vanhoutte PM. Atrial natriuretic peptide decreases cardiac output independently of coronary vasoconstriction. Proc Soc Exp Biol Med 1987; 186: 313-318.
117. Shen YT, Young MA, Ohanian RM, Vatner SF. Atrial natriuretic factor-induced systemic vasoconstriction in conscious dogs, rats, and monkeys. Circ Res 1990; 66: 647-661.
118. Woods RL, Anderson WP. Atrial natriuretic peptide infusion causes vasoconstriction after autonomic blockade in conscious dogs. Am J Physiol 1990; 259: R813-R822.
119. Shen YT, Graham RM, Vatner SF. Effects of atrial natriuretic factor on blood flow distribution and vascular resistance in conscious dogs. Am J Physiol 1991; 260: H1893-H1902.
120. Woods RL, Smolich JJ. Regional blood flow effects of ANP in conscious dogs: preferential gastrointestinal vasoconstriction. Am J Physiol 1991; 261: H1961-H1969.
121. Woods RL, Jones MJ. Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs. Am J Physiol 1999; 276: R1443-R1552.